 Kristen Boyle
Concepts (222)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obesity | 22 | 2025 | 2982 | 2.680 |
Why?
| | Adiposity | 10 | 2025 | 518 | 2.020 |
Why?
| | Fatty Acids | 7 | 2024 | 442 | 1.780 |
Why?
| | Pediatric Obesity | 7 | 2025 | 590 | 1.720 |
Why?
| | Lipid Metabolism | 10 | 2024 | 512 | 1.410 |
Why?
| | Umbilical Cord | 4 | 2025 | 85 | 1.270 |
Why?
| | DNA Methylation | 5 | 2023 | 640 | 1.180 |
Why?
| | Muscle, Skeletal | 8 | 2017 | 1710 | 1.050 |
Why?
| | Pregnancy | 22 | 2025 | 6728 | 0.990 |
Why?
| | Prenatal Exposure Delayed Effects | 5 | 2025 | 605 | 0.960 |
Why?
| | Pregnancy Complications | 2 | 2021 | 524 | 0.840 |
Why?
| | Circadian Clocks | 1 | 2023 | 50 | 0.830 |
Why?
| | Infant, Newborn | 13 | 2025 | 6033 | 0.830 |
Why?
| | Adipogenesis | 3 | 2023 | 55 | 0.800 |
Why?
| | Mitochondrial Proteins | 3 | 2014 | 256 | 0.760 |
Why?
| | AMP-Activated Protein Kinases | 4 | 2024 | 197 | 0.750 |
Why?
| | Mothers | 3 | 2025 | 752 | 0.660 |
Why?
| | Fatty Acid Desaturases | 1 | 2020 | 32 | 0.640 |
Why?
| | Diabetes, Gestational | 2 | 2014 | 316 | 0.630 |
Why?
| | Mitochondria | 7 | 2022 | 946 | 0.630 |
Why?
| | Transgenes | 1 | 2020 | 179 | 0.620 |
Why?
| | Diet, High-Fat | 2 | 2020 | 247 | 0.620 |
Why?
| | Spectrophotometry | 1 | 2019 | 60 | 0.600 |
Why?
| | Electron Transport Complex I | 1 | 2019 | 41 | 0.600 |
Why?
| | Enzymes | 1 | 2019 | 67 | 0.590 |
Why?
| | Maternal Exposure | 1 | 2020 | 188 | 0.570 |
Why?
| | Caenorhabditis elegans Proteins | 1 | 2020 | 198 | 0.550 |
Why?
| | Oxidation-Reduction | 9 | 2021 | 1059 | 0.550 |
Why?
| | Oxidative Stress | 3 | 2020 | 1314 | 0.520 |
Why?
| | Birth Weight | 4 | 2024 | 514 | 0.510 |
Why?
| | Fenofibrate | 1 | 2016 | 28 | 0.510 |
Why?
| | PPAR gamma | 2 | 2016 | 182 | 0.480 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2015 | 82 | 0.480 |
Why?
| | Infant | 12 | 2025 | 9398 | 0.470 |
Why?
| | Female | 30 | 2025 | 72787 | 0.460 |
Why?
| | Dietary Fats | 3 | 2010 | 304 | 0.440 |
Why?
| | Allostasis | 2 | 2025 | 17 | 0.430 |
Why?
| | Electron Transport Complex II | 1 | 2013 | 26 | 0.420 |
Why?
| | Muscle Development | 3 | 2021 | 111 | 0.420 |
Why?
| | beta Catenin | 1 | 2015 | 253 | 0.420 |
Why?
| | Muscle Proteins | 1 | 2014 | 228 | 0.400 |
Why?
| | Sirtuin 3 | 1 | 2013 | 61 | 0.390 |
Why?
| | Calcium Signaling | 1 | 2014 | 249 | 0.390 |
Why?
| | Triglycerides | 4 | 2024 | 524 | 0.390 |
Why?
| | DNA, Mitochondrial | 2 | 2022 | 200 | 0.380 |
Why?
| | Placenta | 4 | 2023 | 749 | 0.370 |
Why?
| | Insulin | 8 | 2022 | 2406 | 0.370 |
Why?
| | Muscle Fibers, Skeletal | 3 | 2011 | 216 | 0.360 |
Why?
| | Lipid Peroxidation | 1 | 2011 | 153 | 0.360 |
Why?
| | Superoxide Dismutase | 1 | 2013 | 346 | 0.350 |
Why?
| | Glucose | 3 | 2023 | 1019 | 0.350 |
Why?
| | Humans | 39 | 2025 | 136764 | 0.340 |
Why?
| | Fluorocarbons | 2 | 2023 | 117 | 0.340 |
Why?
| | Precision Medicine | 2 | 2025 | 426 | 0.340 |
Why?
| | Environmental Pollutants | 2 | 2023 | 156 | 0.330 |
Why?
| | Electron Transport | 4 | 2019 | 115 | 0.310 |
Why?
| | Body Mass Index | 8 | 2025 | 2375 | 0.290 |
Why?
| | Fatty Acids, Nonesterified | 2 | 2022 | 159 | 0.270 |
Why?
| | Child, Preschool | 9 | 2025 | 11000 | 0.260 |
Why?
| | Insulin, Regular, Human | 2 | 2022 | 43 | 0.240 |
Why?
| | Child | 9 | 2025 | 21822 | 0.220 |
Why?
| | Adult | 15 | 2025 | 37630 | 0.220 |
Why?
| | Male | 20 | 2025 | 67309 | 0.220 |
Why?
| | ARNTL Transcription Factors | 1 | 2023 | 17 | 0.220 |
Why?
| | Fetal Blood | 2 | 2023 | 327 | 0.210 |
Why?
| | Caprylates | 1 | 2023 | 25 | 0.210 |
Why?
| | Hypertrophy | 1 | 2023 | 133 | 0.200 |
Why?
| | Disease Susceptibility | 1 | 2025 | 345 | 0.200 |
Why?
| | Cells, Cultured | 3 | 2016 | 4190 | 0.200 |
Why?
| | Cannabidiol | 1 | 2024 | 119 | 0.200 |
Why?
| | Cell Differentiation | 2 | 2023 | 1982 | 0.190 |
Why?
| | Dronabinol | 1 | 2024 | 226 | 0.190 |
Why?
| | Obesity, Metabolically Benign | 1 | 2021 | 4 | 0.190 |
Why?
| | Pregnancy Proteins | 1 | 2022 | 36 | 0.190 |
Why?
| | Metabolic Flux Analysis | 1 | 2021 | 7 | 0.180 |
Why?
| | Fetal Development | 1 | 2025 | 296 | 0.180 |
Why?
| | Adipocytes | 1 | 2023 | 222 | 0.180 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2021 | 9 | 0.180 |
Why?
| | Mitogen-Activated Protein Kinase 9 | 1 | 2021 | 18 | 0.180 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2021 | 42 | 0.170 |
Why?
| | Fasting | 1 | 2023 | 280 | 0.170 |
Why?
| | Metabolic Networks and Pathways | 1 | 2021 | 180 | 0.170 |
Why?
| | Carnitine O-Palmitoyltransferase | 2 | 2017 | 46 | 0.160 |
Why?
| | Premature Birth | 1 | 2023 | 331 | 0.160 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2021 | 283 | 0.160 |
Why?
| | Aconitate Hydratase | 1 | 2019 | 17 | 0.150 |
Why?
| | Young Adult | 6 | 2017 | 13129 | 0.150 |
Why?
| | Gene Expression | 1 | 2023 | 1500 | 0.150 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2021 | 316 | 0.150 |
Why?
| | Carnitine | 3 | 2017 | 84 | 0.150 |
Why?
| | Pilot Projects | 1 | 2023 | 1692 | 0.150 |
Why?
| | Autism Spectrum Disorder | 1 | 2023 | 395 | 0.140 |
Why?
| | Phosphorylation | 3 | 2021 | 1758 | 0.140 |
Why?
| | Metabolic Syndrome | 1 | 2021 | 354 | 0.140 |
Why?
| | Acetyl-CoA Carboxylase | 1 | 2017 | 33 | 0.140 |
Why?
| | Animals | 6 | 2023 | 36823 | 0.140 |
Why?
| | Insulin Resistance | 4 | 2025 | 1203 | 0.130 |
Why?
| | Caenorhabditis elegans | 1 | 2020 | 305 | 0.130 |
Why?
| | Mice, Transgenic | 2 | 2020 | 2160 | 0.130 |
Why?
| | Environmental Exposure | 1 | 2020 | 572 | 0.120 |
Why?
| | Niacinamide | 1 | 2016 | 79 | 0.120 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2015 | 72 | 0.120 |
Why?
| | Glucose Tolerance Test | 2 | 2014 | 364 | 0.120 |
Why?
| | Longitudinal Studies | 3 | 2020 | 2829 | 0.120 |
Why?
| | Amino Acids | 2 | 2017 | 497 | 0.120 |
Why?
| | Transcription Factors | 1 | 2023 | 1718 | 0.120 |
Why?
| | Diabetes Mellitus | 1 | 2023 | 1032 | 0.110 |
Why?
| | Adenylate Kinase | 1 | 2014 | 26 | 0.110 |
Why?
| | Exercise Tolerance | 1 | 2017 | 279 | 0.110 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2015 | 134 | 0.110 |
Why?
| | Glutathione | 2 | 2013 | 356 | 0.110 |
Why?
| | Metabolome | 1 | 2017 | 350 | 0.100 |
Why?
| | Prediabetic State | 1 | 2016 | 253 | 0.100 |
Why?
| | Interleukin-1 | 1 | 2017 | 964 | 0.100 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2017 | 858 | 0.100 |
Why?
| | Cardiovascular Diseases | 1 | 2023 | 2104 | 0.090 |
Why?
| | Uncoupling Protein 3 | 1 | 2010 | 8 | 0.090 |
Why?
| | Pyruvate Dehydrogenase (Lipoamide) | 1 | 2010 | 10 | 0.090 |
Why?
| | Membrane Proteins | 1 | 2017 | 1163 | 0.090 |
Why?
| | PPAR alpha | 1 | 2010 | 58 | 0.090 |
Why?
| | Lipolysis | 1 | 2010 | 46 | 0.080 |
Why?
| | Ion Channels | 1 | 2010 | 133 | 0.080 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2010 | 180 | 0.080 |
Why?
| | Subcutaneous Fat | 1 | 2010 | 81 | 0.080 |
Why?
| | Signal Transduction | 2 | 2022 | 5075 | 0.080 |
Why?
| | Inflammation | 2 | 2022 | 2834 | 0.080 |
Why?
| | Metabolomics | 1 | 2015 | 678 | 0.080 |
Why?
| | Diet | 2 | 2022 | 1274 | 0.080 |
Why?
| | Rodentia | 1 | 2009 | 57 | 0.080 |
Why?
| | Epigenesis, Genetic | 2 | 2023 | 657 | 0.080 |
Why?
| | Myostatin | 1 | 2008 | 25 | 0.070 |
Why?
| | Energy Metabolism | 3 | 2022 | 919 | 0.070 |
Why?
| | Mice | 4 | 2020 | 17733 | 0.070 |
Why?
| | TOR Serine-Threonine Kinases | 2 | 2022 | 412 | 0.070 |
Why?
| | Prostatic Neoplasms | 1 | 2015 | 1034 | 0.070 |
Why?
| | Proteomics | 1 | 2014 | 1109 | 0.070 |
Why?
| | Hydrogen Peroxide | 1 | 2009 | 327 | 0.070 |
Why?
| | Adolescent | 5 | 2016 | 21382 | 0.070 |
Why?
| | Gene Expression Regulation | 2 | 2017 | 2605 | 0.060 |
Why?
| | Cohort Studies | 1 | 2015 | 5701 | 0.060 |
Why?
| | Obesity, Morbid | 1 | 2008 | 259 | 0.050 |
Why?
| | Cell Proliferation | 1 | 2011 | 2472 | 0.050 |
Why?
| | Exercise | 2 | 2022 | 2043 | 0.050 |
Why?
| | Blood Glucose | 2 | 2010 | 2181 | 0.050 |
Why?
| | RNA, Messenger | 1 | 2010 | 2831 | 0.050 |
Why?
| | Hydrocortisone | 1 | 2025 | 322 | 0.050 |
Why?
| | Weight Loss | 1 | 2008 | 776 | 0.050 |
Why?
| | Prospective Studies | 2 | 2025 | 7572 | 0.050 |
Why?
| | Bayes Theorem | 1 | 2023 | 404 | 0.050 |
Why?
| | Breast Feeding | 1 | 2024 | 439 | 0.040 |
Why?
| | Biomarkers | 3 | 2020 | 4143 | 0.040 |
Why?
| | Gestational Age | 1 | 2023 | 902 | 0.040 |
Why?
| | Consensus | 1 | 2023 | 678 | 0.040 |
Why?
| | Skinfold Thickness | 1 | 2020 | 46 | 0.040 |
Why?
| | Child Development | 1 | 2024 | 464 | 0.040 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2020 | 109 | 0.040 |
Why?
| | Leukocytes, Mononuclear | 1 | 2022 | 558 | 0.040 |
Why?
| | Risk Factors | 2 | 2025 | 10326 | 0.040 |
Why?
| | Evidence-Based Medicine | 1 | 2023 | 738 | 0.040 |
Why?
| | In Vitro Techniques | 1 | 2021 | 1089 | 0.040 |
Why?
| | Colorado | 2 | 2020 | 4518 | 0.040 |
Why?
| | Sex Characteristics | 1 | 2023 | 759 | 0.040 |
Why?
| | Stem Cells | 1 | 2022 | 592 | 0.040 |
Why?
| | Muscle Cells | 1 | 2017 | 43 | 0.030 |
Why?
| | Rotarod Performance Test | 1 | 2017 | 16 | 0.030 |
Why?
| | Aged | 2 | 2016 | 23794 | 0.030 |
Why?
| | Middle Aged | 3 | 2016 | 33228 | 0.030 |
Why?
| | Mitochondrial Diseases | 1 | 2017 | 91 | 0.030 |
Why?
| | Cell Respiration | 1 | 2017 | 102 | 0.030 |
Why?
| | Stress, Psychological | 1 | 2025 | 1097 | 0.030 |
Why?
| | Myoblasts | 1 | 2017 | 84 | 0.030 |
Why?
| | Sirtuin 1 | 1 | 2016 | 30 | 0.030 |
Why?
| | Plethysmography | 1 | 2016 | 106 | 0.030 |
Why?
| | Receptors, Interleukin-1 | 1 | 2017 | 216 | 0.030 |
Why?
| | Oxidative Phosphorylation | 1 | 2017 | 193 | 0.030 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2017 | 176 | 0.030 |
Why?
| | Epoxy Compounds | 1 | 2015 | 33 | 0.030 |
Why?
| | Heterografts | 1 | 2015 | 138 | 0.030 |
Why?
| | Postprandial Period | 1 | 2015 | 107 | 0.030 |
Why?
| | Running | 1 | 2017 | 230 | 0.030 |
Why?
| | Physical Conditioning, Animal | 1 | 2017 | 256 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 851 | 0.030 |
Why?
| | Exercise Test | 1 | 2017 | 625 | 0.030 |
Why?
| | Positron-Emission Tomography | 1 | 2015 | 293 | 0.030 |
Why?
| | Mice, Nude | 1 | 2015 | 696 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2017 | 1350 | 0.030 |
Why?
| | Polymerase Chain Reaction | 1 | 2016 | 1059 | 0.030 |
Why?
| | Lipopolysaccharides | 1 | 2017 | 886 | 0.030 |
Why?
| | Lipids | 1 | 2017 | 665 | 0.030 |
Why?
| | Mice, Inbred C57BL | 2 | 2017 | 5735 | 0.020 |
Why?
| | Cell Line | 1 | 2017 | 2837 | 0.020 |
Why?
| | Cholesterol | 2 | 2010 | 410 | 0.020 |
Why?
| | Microdialysis | 1 | 2010 | 51 | 0.020 |
Why?
| | Glycerol | 1 | 2010 | 94 | 0.020 |
Why?
| | Cholesterol, HDL | 1 | 2010 | 203 | 0.020 |
Why?
| | Glutathione Disulfide | 1 | 2009 | 33 | 0.020 |
Why?
| | Adenosine Diphosphate | 1 | 2009 | 79 | 0.020 |
Why?
| | Catalase | 1 | 2009 | 130 | 0.020 |
Why?
| | Glucose Clamp Technique | 1 | 2009 | 195 | 0.020 |
Why?
| | Immunoblotting | 1 | 2008 | 306 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2015 | 3405 | 0.020 |
Why?
| | Oligopeptides | 1 | 2009 | 271 | 0.020 |
Why?
| | Chromatography, Liquid | 1 | 2008 | 433 | 0.020 |
Why?
| | Gastric Bypass | 1 | 2008 | 119 | 0.020 |
Why?
| | Hypolipoproteinemias | 1 | 1986 | 2 | 0.020 |
Why?
| | Hypoglycemic Agents | 1 | 2015 | 1283 | 0.020 |
Why?
| | Hyperlipoproteinemias | 1 | 1986 | 6 | 0.020 |
Why?
| | Oxygen Consumption | 1 | 2009 | 695 | 0.020 |
Why?
| | Tandem Mass Spectrometry | 1 | 2008 | 532 | 0.010 |
Why?
| | Antioxidants | 1 | 2009 | 584 | 0.010 |
Why?
| | Body Weight | 1 | 2008 | 985 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2009 | 2486 | 0.010 |
Why?
| | Rats | 1 | 2009 | 5639 | 0.010 |
Why?
| | Cross-Sectional Studies | 1 | 2008 | 5423 | 0.010 |
Why?
| | Xanthomatosis | 1 | 1986 | 9 | 0.000 |
Why?
| | Nutritional Physiological Phenomena | 1 | 1986 | 54 | 0.000 |
Why?
| | Lipoproteins, HDL | 1 | 1986 | 77 | 0.000 |
Why?
| | Arterial Occlusive Diseases | 1 | 1986 | 80 | 0.000 |
Why?
| | Physical Exertion | 1 | 1986 | 215 | 0.000 |
Why?
| | Electrocardiography | 1 | 1986 | 629 | 0.000 |
Why?
| | Heart Rate | 1 | 1986 | 820 | 0.000 |
Why?
| | Blood Pressure | 1 | 1986 | 1774 | 0.000 |
Why?
|
|
Boyle's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|